$AKCA

Akcea Therapeutics, Inc. IPO Preview

Company: Akcea Therapeutics, Inc. Symbol: AKCA Description: They are a late-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. Shares: 9.62 million Price Range: $12.00-$14.00 Trade Date: 6/30 Underwriter(s): Cowen and Company, Stifel, Wells Fargo Securities Co-Manager: BMO Capital Markets Link to S-1/A Prospectus[…]

Healthcare in spotlight for busy final week of June

SIGN UP FOR IPO BOUTIQUE’S FREE NEWSLETTER There are ten IPOs on the schedule for this week including five healthcare offerings. Below is the IPO schedule for the upcoming week: Tuesday – 6/27 Avenue Therapeutics (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl,[…]

IPO Pipeline Update: New Filings & Updated Terms (Week ending 6.23.17)

New Filings & Updated Terms (Week ending 6.23.17) IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included. NEW FILINGS Company: Vencore Holding Corp. Symbol: VNCR Description: Vencore is a leading provider of mission-critical, innovation-driven services[…]

IPO Filings & Terms 3.31.17

NEW FILINGS Company: A.S.V., LLC Symbol: ASV Price: TBD Description: They design and manufacture a broad range of high quality compact track loader and skid steer loader equipment, marketed through a distribution network in North America, Australia and New Zealand under the ASV and Terex brands. Trade Date: TBD Shares: TBD Underwriter(s): Roth Capital Partners[…]

Scroll to top
error: Content is protected !!